Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Published:2023-05 Issue:3 Volume:24 Page:218-227
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Johnson Melissa L.,Strauss James,Patel Manish R.,Garon Edward B.,Eaton Keith D.,Neskorik Tavette,Morin Josée,Chao Richard,Halmos Balazs

Funder

Merck

Mirati Therapeutics

AstraZeneca

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Cancer Statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Real-world effectiveness of immunotherapies in pre-treated, advanced non-small cell lung cancer patients: A systematic literature review;Juarez-Garcia;Lung Cancer,2022

3. Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab;Lee;Sci Rep,2017

4. Role of PD-L1 expression in non-small cell lung cancer and the prognostic significance according to clinicopathological factors and diagnostic markers;Pawelczyk;Int J Mol Sci,2019

5. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma;Govindan;J Immunother Cancer,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic control of immunoevasion in cancer stem cells;Trends in Cancer;2024-09

2. HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells;European Journal of Medicinal Chemistry;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3